🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsInternationalUK Boots vs LloydsPharmacy — 12 month update Page 7

UK Boots vs LloydsPharmacy — 12 month update

LipidDoc_ATL Mon, Dec 15, 2025 at 8:53 PM 39 replies 1,780 viewsPage 7 of 8
BiostatsBrad
Member
456
2,345
Jul 2024
Durham, NC
Mar 19, 2026 at 1:37 PM#31

Adding the numbers, since they settle part of this. Practical: whatever you change, write down the date and the reason. In three months the reason is what you will have forgotten, and the reason is what makes the record worth having.

Last edited: Mar 19, 2026 at 2:37 PM
2 0LindaRN_retired, tommy_boulder
Reply Quote Save Share Report
anders_CPH
Senior Member
1,567
7,234
Feb 2024
Copenhagen, DK
Mar 27, 2026 at 1:07 AM#32

Following on from hans_munich — and this may be the naive question:

Did your prescriber agree with that reading, and if not what was their objection?

3 1MariaRD, AussieAnna, BethLabQueen
Reply Quote Save Share Report
NauseaFreeNow
Member
345
1,234
Aug 2024
Indiana
Apr 3, 2026 at 12:42 PM#33
BiostatsBrad said:
Practical: whatever you change, write down the date and the reason.

Filing a mild objection. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit. Not convinced. The evidence being cited is consistent with the conclusion and also consistent with two other conclusions nobody has ruled out.

4 2Dr.PulmRoch, maya_sedona, stefan_berlin and 1 other
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
CanadaChris
Member
234
890
Nov 2024
Toronto, CA
Apr 11, 2026 at 12:21 AM#34
BiostatsBrad said:
Practical: whatever you change, write down the date and the reason.

Correct, and worth adding that it is reversible. Nothing being described here is a one-way door, which changes how cautious it is reasonable to be.

Last edited: Apr 11, 2026 at 6:21 AM
5 3Dr.PulmRoch, maya_sedona, stefan_berlin and 2 others
Reply Quote Save Share Report
Dr.MetabolicMD
VIP Member
2,345
16,789
Jan 2024
Rochester, MN
Apr 18, 2026 at 12:04 PM#35
BiostatsBrad said:
Practical: whatever you change, write down the date and the reason.

Thank you — that is the clearest version of this I have read, and I have read a lot of them. Adding it to my notes with a link back to this thread.

Last edited: Apr 18, 2026 at 2:04 PM
6 4GenomicsKate, Dr.ObesityMed, HealthEcon_DC and 3 others
Reply Quote Save Share Report

Similar Threads

EU EMA compounding guidance — 2026 regulatory update9 replies
UK NHS GLP-1 prescribing — NICE TA875 and access guide7 replies
Australian TGA scheduling changes — peptide access 20268 replies
Canadian GLP-1 coverage — provincial formulary comparison6 replies
Purchasing GLP-1 in Mexico — legality, quality, and safety concerns6 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register